CA3041016C - Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles - Google Patents
Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles Download PDFInfo
- Publication number
- CA3041016C CA3041016C CA3041016A CA3041016A CA3041016C CA 3041016 C CA3041016 C CA 3041016C CA 3041016 A CA3041016 A CA 3041016A CA 3041016 A CA3041016 A CA 3041016A CA 3041016 C CA3041016 C CA 3041016C
- Authority
- CA
- Canada
- Prior art keywords
- estetrol
- component
- dysmenorrhea
- estetrol component
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une méthode de prise en charge de la dysménorrhée, consistant à administrer un composant strogénique qui est de préférence sélectionné dans le groupe constitué par l'estétrol et des composés de type estétrol. Étonnamment, les composés de type estétrol se sont révélés aptes à atténuer la dysménorrhée, lorsqu'ils sont utilisés seuls ou combinés à des composés progestatifs, dans une mesure qui dépasse l'effet obtenu avec d'autres compositions, et avec un profil d'effets secondaires avantageux par rapport aux méthodes actuellement disponibles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3178291A CA3178291A1 (fr) | 2016-08-05 | 2016-10-28 | Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2016/076104 WO2018065076A1 (fr) | 2016-10-28 | 2016-10-28 | Méthode de prise en charge de la dysménorrhée et des douleurs menstruelles |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3178291A Division CA3178291A1 (fr) | 2016-08-05 | 2016-10-28 | Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles |
Publications (2)
Publication Number | Publication Date |
---|---|
CA3041016A1 CA3041016A1 (fr) | 2018-04-12 |
CA3041016C true CA3041016C (fr) | 2023-09-05 |
Family
ID=57209484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3041016A Active CA3041016C (fr) | 2016-08-05 | 2016-10-28 | Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2018533542A (fr) |
KR (1) | KR20190076014A (fr) |
AU (1) | AU2016425935B2 (fr) |
CA (1) | CA3041016C (fr) |
WO (1) | WO2018065076A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2383279A1 (fr) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Procédé de préparation d'estetrol |
EP3701944B1 (fr) | 2015-06-18 | 2021-12-08 | Estetra SRL | Unité posologique orodispersible contenant un composant d'estétrol |
CN116077454A (zh) | 2015-06-18 | 2023-05-09 | 埃斯特拉有限责任公司 | 含雌四醇组分的口腔分散剂量单位 |
DK3310345T3 (da) | 2015-06-18 | 2021-05-25 | Estetra Sprl | Orodispersibel tablet indeholdende estetrol |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
EP3749327A1 (fr) | 2018-02-07 | 2020-12-16 | Estetra SPRL | Composition contraceptive présentant des effets cardiovasculaires réduits |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
HU231240B1 (hu) | 2019-09-03 | 2022-04-28 | Richter Gedeon Nyrt. | Ipari eljárás nagytisztaságú ösztetrol hatóanyag előállítására |
IT202000003964A1 (it) * | 2020-02-26 | 2021-08-26 | Umberto Cornelli | Composizione farmaceutica per l’uso nel trattamento di dismenorrea e/o sindrome premestruale |
CN116669732A (zh) * | 2021-02-02 | 2023-08-29 | 广州沪同有梧生物科技有限公司 | Pqq及其衍生物的新应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4344405C2 (de) | 1993-12-24 | 1995-12-07 | Marika Dr Med Ehrlich | Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption |
WO2012055840A1 (fr) * | 2010-10-28 | 2012-05-03 | Bayer Pharma Aktiengesellschaft | Composition et préparation pour le traitement de la dysménorrhée et de la douleur menstruelle et utilisation d'un agent hormonal et d'un sel de zinc pour le traitement de troubles menstruels |
KR20220144885A (ko) * | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
-
2016
- 2016-10-28 CA CA3041016A patent/CA3041016C/fr active Active
- 2016-10-28 JP JP2017529086A patent/JP2018533542A/ja active Pending
- 2016-10-28 KR KR1020197015235A patent/KR20190076014A/ko not_active Application Discontinuation
- 2016-10-28 WO PCT/EP2016/076104 patent/WO2018065076A1/fr active Application Filing
- 2016-10-28 AU AU2016425935A patent/AU2016425935B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20190076014A (ko) | 2019-07-01 |
JP2018533542A (ja) | 2018-11-15 |
CA3041016A1 (fr) | 2018-04-12 |
WO2018065076A1 (fr) | 2018-04-12 |
AU2016425935B2 (en) | 2023-01-19 |
AU2016425935A1 (en) | 2019-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2022231672B2 (en) | Method for the management of dysmenorrhea and menstrual pain | |
CA3041016C (fr) | Methode de prise en charge de la dysmenorrhee et des douleurs menstruelles | |
RU2169567C2 (ru) | Способ контрацепции женщин репродуктивного возраста, не достигших предменопаузы | |
KR101812160B1 (ko) | 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리 | |
US20200046729A1 (en) | Methods using combined oral contraceptive compositions with reduced cardiovascular effects | |
NZ262657A (en) | Hormone replacement therapy using estrogen and antiprogestin | |
IL187471A (en) | Quadraphasic continuous graduated estrogen contraceptive | |
EP1796725B1 (fr) | Traitement ou prevention des hemorragies occasionnelles chez les femmes sous progestogenotherapie | |
JP2007533681A (ja) | 天然エストロゲンに基づく段階型避妊製剤 | |
Von Schoultz | Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment | |
JP2008527018A (ja) | 避妊用医薬製剤 | |
JPH08508502A (ja) | 骨粗しょう症の治療方法および治療用組成物 | |
US20080280861A1 (en) | Method of Female Contraception and a Kit For Use Therein | |
Burkman | Chapter Hormonal Contraception |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20210504 |
|
EEER | Examination request |
Effective date: 20210504 |
|
EEER | Examination request |
Effective date: 20210504 |
|
EEER | Examination request |
Effective date: 20210504 |
|
EEER | Examination request |
Effective date: 20210504 |
|
EEER | Examination request |
Effective date: 20210504 |
|
EEER | Examination request |
Effective date: 20210504 |